GetTopicDetailResponse(id=07a84149f2, topicName=CAT-T, introduction=CAT-T, content=null, image=null, comments=1, allHits=792, url=https://h5.medsci.cn/topic?id=4149, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=44598, tagList=[TagDto(tagId=44598, tagName=CAT-T)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=888892, encodeId=74b5888892c9, content=<a href='/topic/show?id=07a84149f2' target=_blank style='color:#2F92EE;'>#CAT-T#</a>持久性關注, objectTitle=Blood：CD19靶向CAR T細胞二次輸注治療難治性B細胞惡性腫瘤的預后及相關因素, objectType=article, longId=201329, objectId=4e25201329bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020928/1601261605027_2110107.PNG, objectUrl=/article/show_article.do?id=4e25201329bf, replyNumber=0, likeNumber=177, createdTime=2020-09-28, rootId=0, userName=神盾醫(yī)療局局長Jack, userId=ab235268530, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e25201329bf, moduleTitle=Blood：CD19靶向CAR T細胞二次輸注治療難治性B細胞惡性腫瘤的預后及相關因素, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4e25201329bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
